Author

B. Hudson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:spatial domain detection· 1

Frequent Co-Authors

J. J. Post· 2 shared M. Martinello· 2 shared N. Gilroy· 2 shared R. A. Bull· 2 shared A. Abayasingam· 1 shared A. Adhikari· 1 shared A. Choi· 1 shared A. G. Stewart· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

J. J. Post

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epithelia

D. C. Castaneda, S. Jangra, M. Yurieva, J. Martinek, M. Callender, M. Coxe, A. Choi, J. G.-B. Diego, J. Lin, T.-C. Wu, F. Marches, D. Chaussabel, P. Yu, A. Salner, G. Aucello, , K. Palucka

This study examines the spatiotemporal immune response to SARS-CoV-2 in human broncho-alveolar epithelia, finding variant-specific kinetics and spatially organized gene expression patterns.

bioRxiv · Mar 30, 2023Immunology

Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients

R. Rouet, J. Y. Henry, M. D. Johansen, M. Sobti, H. Balachandran, D. B. Langley, G. Walker, H. Lenthall, J. Jackson, S. Ubiparipovic, O. Mazigi, P. Schofield, D. L. Burnett, S. H. J. Brown, M. Martinello, , D. Christ

This paper isolates broadly neutralizing SARS-CoV-2 antibodies from convalescent patients and shows they neutralize emerging variants more effectively than existing monoclonal antibodies.

bioRxiv · Oct 19, 2022Immunology

Longitudinal characterisation of phagocytic and neutralisation functions of anti-Spike antibodies in plasma of patients after SARS-CoV-2 infection.

A. Adhikari, A. Abayasingam, C. Rodrigo, D. Agapiou, E. Pandzic, N. A. Brasher, B. S. M. Fernando, E. Keoshkerian, H. Li, H. N. Kim, M. Lord, G. Popovic, W. Rawlinson, M. Mina, J. J. Post, , N. Tedla

This study shows that phagocytic and neutralisation functions of anti-Spike antibodies persist in SARS-CoV-2 convalescents despite declining antibody titers, with improved antibody affinity correlating with maintained effector functions.

bioRxiv · Dec 21, 2021 · PreprintImmunology